A Comparative Study of Uroflowmetry between Preoperative and Postoperative Transurethral Resection of Prostate in Patients with Benign Prostatic Hyperplasia at Tertiary Care Centre, Hapur

Introduction: Benign prostatic hyperplasia (BPH) is a prevalent condition among aging men, leading to lower urinary tract symptoms (LUTS) such as urinary frequency, urgency, and weak stream. Transurethral resection of the prostate (TURP) is a widely accepted surgical intervention for alleviating these symptoms. This study aimed to compare uroflowmetry parameters and International Prostate Symptom Scores (IPSS) pre- and post-TURP in patients with BPH at a tertiary care center in Hapur. Objectives: 1) To study uroflowmetry preoperatively in lower urinary tract symptoms evaluation due to benign prostatic hyperplasia. 2) To study uroflowmetry postoperatively in lower urinary tract symptom evaluation due to benign prostatic hyperplasia. 3) To compare uroflowmetry before and after transurethral resection of the prostate for benign prostatic hyperplasia. Methods: This prospective study included 50 patients diagnosed with BPH who met the inclusion criteria. Uroflowmetry parameters, including peak flow rate (Qmax), average flow rate (Qavg), voiding time (Tmax), and flow time (Ftm), were assessed pre- and postoperatively. Additionally, IPSS scores were recorded at multiple intervals post-TURP. Results: The study demonstrated significant improvements in uroflowmetry parameters and IPSS scores following TURP. Preoperatively, all patients had a Qmax below 10 ml/sec. Postoperatively, 92% had a Qmax exceeding 15 ml/sec. Similarly, Qavg improved significantly, with 28% achieving values between 10 and 15 ml/sec. Tmax and Ftm also showed notable reductions postoperatively. IPSS scores significantly decreased from a mean of 26.3 preoperatively to 9.14 one month postoperatively, indicating substantial symptom relief and enhanced quality of life. Conclusion: TURP significantly improves uroflowmetry parameters and IPSS scores in patients with BPH. Uroflowmetry serves as an effective tool for assessing symptomatic relief and predicting surgical outcomes, while IPSS provides a comprehensive measure of symptom severity and quality of life improvements post-TURP.